DCGI recommends Covovax as heterologous booster dose

Jan 12, 2023

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as...

Drugs Controller General of India bans all charges, except supply, processing costs on blood units

Jan 04, 2024

The Drugs Controller General of India (DCGI) has waived all charges except processing costs on blood units.

DCGI grants conditional market approval for Covaxin, Covishield

Jan 27, 2022

New Delhi [India], January 27 : The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin...

Zydus Cadila submits additional data to DCGI: Sources

Jul 27, 2021

New Delhi [India], July 27 : Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety to India's drug regulator Drugs Controller...

Zydus Lifesciences gets DCGI approval for Oxemia drug

Mar 07, 2022

Ahmedabad (Gujarat) [India], March 7 : Zydus Lifesciences on Monday said it has received approval from the Drug Controller General of India (DCGI) for...

Cabinet clears Rajeev Singh Raghuvanshi's name as new DCGI

Feb 22, 2023

Dr Singh is scheduled to take charge from 28th February. Till then, Dr PBN Prasad has been appointed to the post on a temporary...